-
Healthcare Stocks Take a Hit After Trepidation In the Market Continues
Wednesday, April 3, 2024 - 6:05pm | 641The United States stock market opened today to a cautious post-Easter floor as healthcare systems see the brunt of trepidation. The U.S. stock market has seen a boom in the first quarter of 2024, which had investors looking forward to the rest of the year, but the sluggish start to April has those...
-
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
Saturday, October 28, 2023 - 12:49pm | 815The U.S. Food and Drug Administration has recently issued a stern warning to the public, advising against the purchase and use of multiple specific over-the-counter eye drop products from prominent brands. The agency has raised concerns about the potential risk of eye...
-
3 Recession-Proof Stocks With Nice Dividends
Monday, May 15, 2023 - 9:41am | 1006Prices and interest rates are higher. American households are strapped for cash. But is the economy really headed into a recession? The Federal Reserve Bank of New York's latest U.S. Recession Probabilities model has the odds of the country entering a negative growth period at 68%. This is the...
-
Biden, Trump, DeSantis: Cramer Says Concerns Over Next President Mean We May Be In For 'Second Leg' Of 'Vicious Rotation' Out Of Healthcare
Tuesday, January 10, 2023 - 9:04am | 402The Health Care Select Sector SPDR Fund (NYSE: XLV) ended 2022 with a modest loss of 2.08%, a relative outperformance vis-a-vis the broader S&P 500 Index, which shed close to 20%. What Happened: CNBC “Mad Money” host Jim Cramer on Tuesday took to Twitter to suggest there could be...
-
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
Friday, December 23, 2022 - 8:46am | 580The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price...
-
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
Thursday, December 15, 2022 - 8:19am | 559The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it...
-
Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look?
Wednesday, December 14, 2022 - 9:23am | 529The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector, with an RSI above or near 70. Novartis AG (NYSE: NVS) Novartis AG (NYSE: NVS) announced detailed...
-
Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
Sunday, November 20, 2022 - 9:48am | 606Jim Simons is the founder and hedge fund manager of Renaissance Technologies, which currently has a total portfolio value north of $77 billion, per Stock Circle. This hedge fund uses a quantitative strategy in determining its stock trades. Simons' quantitative approach has had legendary success...
-
Sectors That Present The Most Opportunity For Retail Investors And Ones To Stay Away From: Benzinga TV Exclusive
Tuesday, October 18, 2022 - 4:41pm | 273On today's (Oct. 18) episode of the "Stock Market Movers," host Mitch Hoch spoke to Eric Schiffer, CEO of The Patriarch Organization, about the biggest opportunities for retail investors. When asked about how the recession, "We are not in the eye of the storm yet," said...
-
Psychedelics May Soon Get Therapy Operating Standards: Here's What APPA Is And Why It Matters
Wednesday, October 12, 2022 - 4:40pm | 395The current state of affairs seems to show that psychedelics-assisted therapy will eventually become part of the healthcare system for those suffering from a diverse range of mental and physical disorders, with most recent and noticeable examples in Alberta, Canada and Oregon. Newly...
-
Recession Investing: 5 High Yield Dividend Stocks For A Downturn
Wednesday, August 3, 2022 - 2:23pm | 676As the healthcare industry absorbed enormous amounts of profits during the Covid-19 pandemic, many healthcare companies will be increasing shareholder distributions to entice investors to buy their stock. With the S&P 500 down roughly 13% year-to-date and the average dividend yield in the...
-
Amazon Set To Face Tough Competition As It Expands Into The Healthcare Industry
Saturday, July 23, 2022 - 3:36pm | 537Amazon.com Inc (NYSE: AMZN) is acquiring 1Life Healthcare Inc (NYSE: ONEM) for $3.9 billion or $18 dollars per share in an all-cash merger agreement, including debt. About One Medical: 1Life Healthcare went public in 2020 and is operating under the name One Medical, providing primary-care services...
-
5 NYSE Healthcare Stocks With The Highest ROI
Wednesday, July 15, 2015 - 9:30am | 179Below are the top NYSE stocks in the healthcare sector in terms of return on investment. The trailing-twelve-month return on investment at Novo Nordisk A/S (ADR) (NYSE: NVO) is 65.50 percent. Novo Nordisk's revenue for the same period is $14.00 billion. The trailing-twelve-month return on...
-
5 NASDAQ Healthcare Stocks With The Highest ROA
Thursday, July 2, 2015 - 9:23am | 172Below are the top NASDAQ stocks in the healthcare sector in terms of return on assets. The trailing-twelve-month return on assets at Enzon Pharmaceuticals Inc (NASDAQ: ENZN) is 88.70 percent. Enzon Pharmaceuticals' revenue for the same period is $27.50 million. The trailing-twelve-month return on...
-
5 NYSE Healthcare Stocks With The Highest ROE
Monday, June 22, 2015 - 9:29am | 173Below are the top NYSE stocks in the healthcare sector in terms of return on equity. The trailing-twelve-month return on equity at GlaxoSmithKline plc (ADR) (NYSE: GSK) is 178.10 percent. GlaxoSmithKline's revenue for the same period is $36.55 billion. The trailing-twelve-month return on equity...